Article

Localization of BCR-ABL to stress granules contributes to its oncogenic function

medRxiv · 2019 · Kashiwagi, S.; Fujioka, Y.; Kondo, T.; Satho, A. O.; Yoshida, A.; Fujioka, M.; Sasajima, H.; Amano, M.; Teshima, T.; Ohba, Y.

Key facts

Title Localization of BCR-ABL to stress granules contributes to its oncogenic function
First author Kashiwagi, S.; Fujioka, Y.; Kondo, T.; Satho, A. O.; Yoshida, A.; Fujioka, M.; Sasajima, H.; Amano, M.; Teshima, T.; Ohba, Y.
Journal medRxiv
Published Oct 20, 2019
DOI 10.1101/801555
Devices mentioned K042152, K914390, K940422, K982100
Product codes mentioned CFN, DDG, DFZ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature